Nazaimoon W M, Ng M L, Satgunasingam N, Khalid B A
Radiochemistry Division, Institute for Medical Research, Jln Pahang, Kuala Lumpur.
Med J Malaysia. 1992 Jun;47(2):103-9.
Growth hormone (GH) levels were measured after a 75g oral glucose load (OGTT) in normal adults, patients with impaired glucose tolerance (IGT), insulin-dependent diabetes mellitus (IDDM) and acromegaly. Nadir GH levels at 2-hour post-OGTT in normal subjects ranged from 0.4 to 8.4 mIU/L, the 95% confidence interval being 0.4-4.4 mIU/L. In IGT and IDDM subjects basal fasting GH levels were not significantly different from normal and did not alter during OGTT. The high fasting GH level measured in one each of the IGT and IDDM patients was suppressible at 1-hour after glucose intake. In contrast, acromegalic patients had elevated fasting GH levels (11.8-178 mIU/L) although in 3 patients, the levels were mildly elevated and overlapped with normal. OGTT failed or only partially suppressed GH secretion in all acromegalics. Therefore, elevated fasting GH levels are not diagnostic and OGTT is required for accurate diagnosis and assessment of treatment of acromegalic patients.
在正常成年人、糖耐量受损(IGT)患者、胰岛素依赖型糖尿病(IDDM)患者和肢端肥大症患者中,口服75克葡萄糖负荷(OGTT)后测量生长激素(GH)水平。正常受试者OGTT后2小时的GH最低点水平在0.4至8.4 mIU/L之间,95%置信区间为0.4 - 4.4 mIU/L。在IGT和IDDM受试者中,基础空腹GH水平与正常水平无显著差异,且在OGTT期间未发生变化。在一名IGT患者和一名IDDM患者中测得的高空腹GH水平在摄入葡萄糖后1小时可被抑制。相比之下,肢端肥大症患者的空腹GH水平升高(11.8 - 178 mIU/L),尽管有3例患者的水平轻度升高且与正常水平重叠。OGTT在所有肢端肥大症患者中未能或仅部分抑制GH分泌。因此,空腹GH水平升高并非诊断依据,准确诊断和评估肢端肥大症患者的治疗需要进行OGTT。